# Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

> **NCT01818648** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01818648
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was withdrawn by PI due to decision to study a different medication.
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818648, "Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01818648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*